Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Net Margin (2016 - 2025)

Dexcom (DXCM) has disclosed Net Margin for 16 consecutive years, with 21.22% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 760.0% to 21.22% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 17.94% through Dec 2025, up 365.0% year-over-year, with the annual reading at 17.94% for FY2025, 365.0% up from the prior year.
  • Net Margin for Q4 2025 was 21.22% at Dexcom, down from 23.47% in the prior quarter.
  • The five-year high for Net Margin was 24.78% in Q4 2023, with the low at 0.76% in Q4 2021.
  • Average Net Margin over 5 years is 13.45%, with a median of 13.36% recorded in 2021.
  • The sharpest move saw Net Margin crashed -7306bps in 2021, then soared 1351bps in 2023.
  • Over 5 years, Net Margin stood at 0.76% in 2021, then surged by 1583bps to 11.26% in 2022, then soared by 120bps to 24.78% in 2023, then crashed by -45bps to 13.62% in 2024, then soared by 56bps to 21.22% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 21.22%, 23.47%, and 15.54% for Q4 2025, Q3 2025, and Q2 2025 respectively.